Skip to main content
. 2021 Aug 11;18(2):474–522. doi: 10.1007/s12015-021-10213-y

Fig. 4.

Fig. 4

Umbilical cord blood derived cells are most frequently used in human clinical trials. (A) Pie chart showing percentage of the types of stem cells tested in trials. (B) Bar graph displaying origin of the transplanted stem cells and corresponding percentages. For both charts, percentages were calculated from all studies listed in Table 5